Each year CCJ produces a dedicated special issue. The 2012 special issue is on cardiovascular disease (CVD). This conference has been designed to compliment this special issue and further enhance the global understanding of CVD.
This state-of-the-art conference brings together world-class leaders in the field of cardiovascular disease (CVD), and features presentations focusing on biomarkers used for the prevention, diagnosis and management of CVD; proteomics and genomics of CVD; and global trends in CVD.
This program is currently co-sponsored by the American Association for Clinical Chemistry, Asia-Pacific Federation of Clinical Biochemistry and Laboratory Medicine, Indonesian Heart Association, Japan Society of Atherosclerosis, Japanese Society of Clinical Chemistry, Singapore Association of Clinical Biochemists, Singapore Cardiac Society, and the Taiwan Society of Cardiology.
This conference is offered under the auspices of the IFCC.
This program is currently supported by DENKA SEIKEN CO., LTD., Health Diagnostic Laboratory, Inc. and Roche Diagnostics.
For information regarding corporate partnership opportunities, please contact Jean Rhame at AACC.